Return to Home Incidence > Table

Incidence Rates Table

Data Options

Incidence Rate Report by State

Ovary (Late Stage^), 2016-2020

All Races (includes Hispanic), Female, All Ages

Sorted by CI*Rank
State
 sort alphabetically by name ascending
Age-Adjusted Incidence Rate
cases per 100,000
(95% Confidence Interval)
 sort by rate descending
CI*Rank⋔
(95% Confidence Interval)
 sort by CI rank descending
Average Annual Count
 sort by count descending
Percent of Cases with Late Stage
 sort by percent late descending
US (SEER+NPCR) 1 6.9 (6.8, 6.9) N/A 13,852 69.7
New York 3 7.9 (7.7, 8.2) 1 (1, 7) 1,022 72.5
Utah 3 7.8 (7.2, 8.5) 2 (1, 22) 114 78.0
New Jersey 3 7.7 (7.4, 8.0) 3 (1, 14) 458 70.0
Idaho 3 7.7 (6.9, 8.5) 4 (1, 28) 82 76.5
West Virginia 6 7.7 (7.0, 8.4) 5 (1, 26) 98 68.3
California 3 7.6 (7.4, 7.8) 6 (2, 13) 1,757 73.4
Pennsylvania 6 7.6 (7.3, 7.8) 7 (1, 15) 682 70.6
Georgia 3 7.4 (7.1, 7.7) 8 (2, 21) 463 77.4
Wisconsin 6 7.3 (6.9, 7.7) 9 (2, 24) 281 73.2
Oregon 6 7.3 (6.9, 7.8) 10 (1, 26) 203 72.8
Iowa 3 7.3 (6.8, 7.9) 11 (1, 29) 152 77.0
South Dakota 6 7.3 (6.3, 8.4) 12 (1, 44) 40 72.1
District of Columbia 6 7.3 (6.1, 8.6) 13 (1, 46) 28 66.3
Connecticut 3 7.3 (6.8, 7.8) 14 (1, 29) 180 78.3
Florida 6 7.1 (6.9, 7.3) 15 (8, 24) 1,109 67.4
Oklahoma 6 7.0 (6.6, 7.5) 16 (3, 34) 171 68.7
Washington 5 7.0 (6.7, 7.4) 17 (7, 30) 322 72.9
Illinois 3 7.0 (6.7, 7.2) 18 (9, 29) 566 69.2
Massachusetts 3 6.9 (6.5, 7.2) 19 (9, 34) 320 72.9
Arkansas 6 6.9 (6.3, 7.4) 20 (4, 40) 136 71.2
Wyoming 6 6.8 (5.6, 8.2) 21 (1, 49) 24 74.1
New Hampshire 6 6.7 (6.0, 7.5) 22 (2, 45) 68 72.5
Maryland 6 6.7 (6.3, 7.1) 23 (12, 39) 268 66.6
Michigan 6 6.6 (6.4, 6.9) 24 (14, 38) 440 72.0
Delaware 6 6.6 (5.8, 7.6) 25 (2, 48) 47 70.8
Montana 6 6.6 (5.7, 7.6) 26 (1, 47) 47 67.3
Texas 3 6.6 (6.4, 6.8) 27 (19, 37) 1,012 65.1
New Mexico 3 6.5 (5.9, 7.2) 28 (7, 46) 88 69.0
North Carolina 6 6.4 (6.1, 6.7) 29 (19, 43) 430 70.0
Kansas 6 6.4 (5.9, 7.0) 30 (12, 46) 116 71.3
Alabama 6 6.4 (6.0, 6.8) 31 (16, 45) 213 63.7
Ohio 6 6.4 (6.1, 6.6) 32 (21, 44) 503 68.5
Vermont 6 6.4 (5.3, 7.6) 33 (1, 49) 28 75.0
Hawaii 3 6.3 (5.6, 7.2) 34 (6, 48) 55 70.8
Colorado 6 6.3 (5.9, 6.7) 35 (18, 46) 208 67.9
Arizona 6 6.2 (5.9, 6.6) 36 (22, 45) 288 66.6
Missouri 6 6.2 (5.9, 6.6) 37 (21, 46) 248 68.3
Minnesota 6 6.2 (5.9, 6.6) 38 (20, 46) 218 65.2
Tennessee 6 6.2 (5.9, 6.5) 39 (22, 46) 273 66.4
Kentucky 3 6.2 (5.8, 6.6) 40 (20, 47) 177 72.6
Rhode Island 6 6.1 (5.3, 7.0) 41 (10, 49) 44 68.3
Virginia 6 6.0 (5.7, 6.3) 42 (29, 47) 326 67.6
Louisiana 3 6.0 (5.6, 6.4) 43 (25, 47) 177 71.6
Alaska 6 6.0 (4.9, 7.3) 44 (2, 49) 22 69.7
North Dakota 6 5.9 (4.8, 7.0) 45 (7, 49) 26 72.3
Nebraska 6 5.8 (5.1, 6.4) 46 (22, 49) 65 66.7
South Carolina 6 5.4 (5.1, 5.8) 47 (40, 49) 188 68.1
Mississippi 6 5.2 (4.8, 5.7) 48 (41, 49) 103 67.1
Maine 6 5.1 (4.5, 5.8) 49 (37, 49) 51 64.6
Indiana 6
data not available
N/A
data not available
data not available
Nevada 6
data not available
N/A
data not available
data not available
Puerto Rico 6 4.6 (4.2, 5.1) N/A 97 62.4
Notes:
Created by statecancerprofiles.cancer.gov on 04/16/2024 11:36 pm.

State Cancer Registries may provide more current or more local data.

Data cannot be shown for the following areas. For more information on what areas are suppressed or not available, please refer to the table.
Indiana, Nevada, Puerto Rico

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.
⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

Data not available for this combination of data selections.

Source: SEER and NPCR data. For more specific information please see the table.
Data not available for this combination of geography, cancer site, age, and race/ethnicity.

Data for the United States does not include data from Nevada.
Data for the United States does not include Puerto Rico.
CI*Rank data for Puerto Rico is not available.

Return to Top